1. Pneumococcal pneumonia. Diagnostic, epidemiologic, therapeutic and prophylactic considerations;Austrian R.;Chest,1986
2. Austrian R 1987. Pneumococcal infections p. 533-537. In E. Braunwald K. J. Isselbacher R. G. Petersdorf J. D. Wilson J. B. Martin and A. S. Fauci (ed.) Harrison's principles of internal medicine 11th ed. McGraw-Hill New York.
3. Beruheimer A. W. 1976. Sulphydryl activated toxins p. 85-97. In A. W. Bernheimer (ed.) Mechanisms in bacterial toxicology. John Wiley and Sons New York.
4. Reduced virulence of a defined pneumolysinnegative mutant of Streptococcus pneumoniae;Berry A. M.;Infect. Immun.,1989
5. Boulnois G. J. T. J. Mitchell K Saunders R. Owen J. Canvin A. Shepherd M. Camara R. Wilson C. Feldman C. Steinfort L. Bashford C. Pasternak and P. W. Andrew. 1991. Analysis of some putative protein virulence factors of Streptococcus pneumoniae p. 83-87. In G. M. Dunny P. P. Cleary and L. L. Mackay (ed.) Streptococcal genetics. American Society for Microbiology Washington D.C.